DIAGNOSTIC TECHNIQUE FOR LATENT ANDROGEN DEFICIENCY IN MEN Russian patent published in 2010 - IPC A61B5/145 A61B10/00 

FIELD: medicine.

SUBSTANCE: invention concerns medicine, namely urology and endocrinology and can be used in androgen therapy caused by physiologically impaired production of testosterone in men. The questioning is presented on the rating scale of age-specific androgen deficiency symptoms (RSAADS). The blood is tested for total testosterone level. The investigations to detect prostate and breast cancer are conducted. That is followed by androgen preparation test, the RSAADS questioning and blood analysis for total testosterone level. The absence of prostate and breast cancer, and increased number of RSAADS points by 9 and more, change of total testosterone level within 25.2 nmol/l to 38.3 nmol/l, then latent androgen deficiency is diagnosed.

EFFECT: method allows detecting the latent forms of androgen deficiency that improves clinical effectiveness in age-specific androgen-deficient conditions and life quality in men.

1 dwg, 1 ex